Dr Reddy’s Laboratories: Global pharmaceutical company, India

  Quick Links
   Company News Coverage
   Sustainability Report
   NCE Pipeline
   Our Values
 
Get it here
             first-hand
  Press Releases

Subscriptions: Want to stay updated? Click here to subscribe to our press releases
Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Feb  | Jan
 
Clarification from Dr Reddy's Laboratories Limited
September 29, 2001
Clinical proof of concept established for DRF-2725 (NN622); Phase 3 expected to begin later this year
September 6, 2001
Distinguished Scientists Recruited to the Scientific Advisory Board of Reddy US Therapeutics, Inc.
September 5, 2001
Dr Reddy's reports FY02 Q1 USGAAP earnings; Net income increases 348% to Rs. 440 million
September 1, 2001




The information contained in the releases was current on the date they were issued and will become or may have become outdated over time. Dr. Reddy's does not assume any responsibility for updating
information in the releases.

  Triple Bottom Line
  Download Brochures
  Key Milestones
   
Designed by
© 2001 - 2008 Dr. Reddy's Laboratories Ltd. All rights reserved
Site best viewed at 800x600 resolution